title: Cryptococcus gattii induces a cytokine pattern that is distinct from other cryptococcal species.
abstract: Understanding more about the host's immune response to different Cryptococcus spp. will provide additional insight into the pathogenesis of cryptocococcis. We hypothesized that the ability of C. gattii to cause disease in immunocompetent humans depends on a distinct innate cytokine response of the host to this emerging pathogen. In the current study we assessed the cytokine profile of human peripheral blood mononuclear cells (PBMCs) of healthy individuals, after in vitro stimulation with 40 different well-defined heat-killed isolates of C. gattii, C. neoformans and several hybrid strains. In addition, we investigated the involvement of TLR2, TLR4 and TLR9 in the pro-inflammatory cytokine response to C. gattii. Isolates of C. gattii induced higher concentrations of the pro-inflammatory cytokines IL-1β, TNF-α and IL-6 and the Th17/22 cytokine IL-17 and IL-22 compared to C. neoformans var neoformans and C. neoformans var grubii. In addition, clinical C. gattii isolates induced higher amounts of cytokines than environmental isolates. This difference was not observed in C. neoformans var. grubii isolates. Furthermore, we demonstrated a likely contribution of TLR4 and TLR9, but no role for TLR2, in the host's cytokine response to C. gattii. In conclusion, clinical heat-killed C. gattii isolates induced a more pronounced inflammatory response compared to other Cryptococcus species and non-clinical C. gattii. This is dependent on TLR4 and TLR9 as cellular receptors.
authors: Department of Medicine and Nijmegen Institute for Infection, Inflammation & Immunity (N4i), Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.
authors: Teske
authors: T
authors: Schoffelen
authors: Maria-Teresa
authors: MT
authors: Illnait-Zaragozi
authors: Leo A B
authors: LA
authors: Joosten
authors: Mihai G
authors: MG
authors: Netea
authors: Teun
authors: T
authors: Boekhout
authors: Jacques F
authors: JF
authors: Meis
authors: Tom
authors: T
authors: Sprong
mesh_terms: D003454:Cryptococcus / Q000145:classification / Q000276:immunology*; D056285:Cryptococcus gattii / Q000276:immunology*; D016207:Cytokines / Q000096:biosynthesis* / Q000276:immunology; D006801:Humans; D007963:Leukocytes, Mononuclear / Q000276:immunology / Q000378:metabolism; D051192:Receptors, Pattern Recognition / Q000378:metabolism; D013045:Species Specificity; D051193:Toll-Like Receptors / Q000378:metabolism
chemical_list: D016207:Cytokines; D051192:Receptors, Pattern Recognition; D051193:Toll-Like Receptors
references: J Immunol. 2008 Mar 15;180(6):4067-74
references: 18322216
references: Curr Opin Crit Care. 2010 Oct;16(5):453-9
references: 20711079
references: Infect Immun. 1993 Feb;61(2):464-9
references: 8423074
references: Infect Immun. 2004 Sep;72(9):5373-82
references: 15322035
references: mBio. 2012 May 08;3(3):
references: 22570277
references: PLoS Pathog. 2010 Apr 22;6(4):e1000850
references: 20421942
references: Nat Immunol. 2009 Aug;10(8):864-71
references: 19578368
references: Infect Immun. 2011 Dec;79(12):4858-67
references: 21947771
references: J Infect Dis. 1991 May;163(5):1108-13
references: 2019758
references: Proc Natl Acad Sci U S A. 2004 Dec 7;101(49):17258-63
references: 15572442
references: Trends Immunol. 2010 Sep;31(9):354-61
references: 20691634
references: Annu Rev Microbiol. 2009;63:223-47
references: 19575556
references: Curr Opin Microbiol. 2008 Aug;11(4):305-12
references: 18602019
references: Clin Infect Dis. 1995 Jul;21(1):28-34; discussion 35-6
references: 7578756
references: J Immunol. 2001 Apr 1;166(7):4620-6
references: 11254720
references: Infect Dis Clin North Am. 2006 Sep;20(3):507-44, v-vi
references: 16984867
references: Eur J Immunol. 2002 May;32(5):1212-22
references: 11981808
references: J Invest Dermatol. 2008 Nov;128(11):2640-2645
references: 18615114
references: FEMS Immunol Med Microbiol. 2006 Jun;47(1):148-54
references: 16706798
references: Infect Immun. 2007 Oct;75(10):4831-7
references: 17606598
references: PLoS One. 2010 Feb 09;5(2):e9124
references: 20161737
references: Proc Natl Acad Sci U S A. 2009 Aug 4;106(31):12980-5
references: 19651610
references: Trends Microbiol. 2011 Nov;19(11):564-71
references: 21880492
references: Infect Immun. 2006 Sep;74(9):5302-10
references: 16926424
references: Eur J Immunol. 2005 Mar;35(3):870-8
references: 15714580
references: BMB Rep. 2009 Dec 31;42(12):776-87
references: 20044948
references: J Clin Invest. 2009 Dec;119(12):3573-85
references: 19920355
references: AIDS. 2009 Feb 20;23(4):525-30
references: 19182676